Mojado, Kent Ian .
HRN: 24-86-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/26/2024
05/03/2024
IV
34 Mg
Q 24
T/C Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes